Atlas Trials

Irritable Bowel Syndrome With Constipation (IBS-C)

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Irritable Bowel Syndrome With Constipation (IBS-C)

RecordFirmDate
Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C (NCT05240521)Devintec Sagl2021-11-01
Post-marketing Surveillance of Linaclotide Tablet in Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation (Excluding Constipation Due to Organic Diseases) (NCT03471728)Astellas Pharma Inc2017-10-02
A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-C (NCT02493036)Theriva Biologics, Inc.2015-10-01
A Study of the Effect of SYN-010 on Subjects With IBS-C (NCT02495623)Theriva Biologics, Inc.2015-06-01
Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome (NCT02316899)Astellas Pharma Inc2014-10-21
Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients (NCT02078323)Augusta University2014-02-01
A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (NCT01880424)AstraZeneca2013-07-01

Track Irritable Bowel Syndrome With Constipation (IBS-C) automatically

Every clearance here is in the API, with alerts when new ones post.